COMPANY OVERVIEW

Cedilla is harnessing intrinsic protein stability mechanisms to broaden the reach of small molecule therapeutics. We work on cancer and other diseases caused by protein dysregulation.

---

LOCATION

Cambridge, MA, USA

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://www.cedillatx.com

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jun 1, 2023

Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology

Feb 4, 2022

Cedilla Therapeutics to Present at Upcoming Investor Conferences

Feb 4, 2022

Cedilla Therapeutics to Present at Upcoming Investor Conferences

Nov 16, 2021

Cedilla Therapeutics Expands Leadership Team with Key Appointments Across RandD And Finance

Oct 25, 2021

Cedilla Therapeutics Completes $82.6M Series B Financing

For More Press Releases

---